C.R.S.
Section 25-20.5-303
Cancer, cardiovascular disease, and chronic pulmonary disease program review committee
(1)
There is hereby created the cancer, cardiovascular disease, and chronic pulmonary disease program review committee. The review committee is established in the prevention services division of the department. The review committee is responsible for overseeing program strategies and activities and ensuring compliance with section 25-20.5-302.(2)
The review committee shall consist of the director of the disease prevention services division of the department, or the director’s designee, and fifteen members appointed as follows:(a)
The executive director of the department or the executive director’s designee.(b)
The executive director shall appoint three members, all of whom are department staff with expertise in cancer, cardiovascular disease, or chronic pulmonary disease.(c)
The state board shall appoint:(I)
One member who is a member of the state board;(II)
One member who is a chronic pulmonary disease professional;(III)
One member who is cardiovascular disease professional;(IV)
One member who is a cancer professional;(V)
Two members who are public health professionals;(VI)
One member who is a recognized expert in health disparities;(VII)
One member who represents the rural interest in regard to the prevention, early detection, and treatment of cancer, cardiovascular disease, and chronic pulmonary disease; and(VIII)
One member who is a primary care provider.(d)
The president of the senate shall appoint one member of the senate.(e)
The speaker of the house of representatives shall appoint one member of the house of representatives.(3)
Intentionally left blank —Ed.(a)
Except as provided in paragraph (b) of this subsection (3), members of the review committee shall serve three-year terms; except that, of the members initially appointed to the review committee, five members appointed by the state board shall serve two-year terms. Members of the review committee appointed pursuant to paragraph (c) of subsection (2) of this section shall not serve more than two consecutive terms.(b)
The terms of the members appointed by the speaker of the house of representatives and the president of the senate and who are serving on March 22, 2007, shall be extended to and expire on or shall terminate on the convening date of the first regular session of the sixty-seventh general assembly. As soon as practicable after such convening date, the speaker and the president shall appoint or reappoint members in the same manner as provided in paragraphs (d) and (e) of subsection (2) of this section. Thereafter, the terms of members appointed or reappointed by the speaker and the president shall expire on the convening date of the first regular session of each general assembly, and all subsequent appointments and reappointments by the speaker and the president shall be made as soon as practicable after such convening date. The person making the original appointment or reappointment shall fill any vacancy by appointment for the remainder of an unexpired term. Members shall serve at the pleasure of the appointing authority and shall continue in office until the member’s successor is appointed.(4)
The composition of the review committee shall reflect, to the extent practical, Colorado’s ethnic, racial, and geographical diversity.(5)
The review committee shall elect from its membership a chair and a vice-chair of the committee.(6)
The division shall provide staff support to the review committee.(7)
Except as otherwise provided in section 2-2-326, C.R.S., members of the review committee shall serve without compensation but shall be reimbursed from moneys deposited in the prevention, early detection, and treatment fund created in section 24-22-117, C.R.S., for their actual and necessary expenses incurred in the performance of their duties pursuant to this part 3.(8)
If a member of the review committee has an immediate personal, private, or financial interest in any matter pending before the review committee, the member shall disclose the fact and shall not vote upon such matter.
Source:
Section 25-20.5-303 — Cancer, cardiovascular disease, and chronic pulmonary disease program review committee, https://leg.colorado.gov/sites/default/files/images/olls/crs2023-title-25.pdf (accessed Oct. 20, 2023).
Up to date